Literature DB >> 15471963

A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.

Wendy W Barclay1, Ralph D Woodruff, M Craig Hall, Scott D Cramer.   

Abstract

The development of normal and abnormal glandular structures in the prostate is controlled at the endocrine and paracrine levels by reciprocal interactions between epithelium and stroma. To study these processes, it is useful to have an efficient method of tissue acquisition for reproducible isolation of cells from defined histologies. Here we assessed the utility of a standardized system for acquisition and growth of prostatic cells from different regions of the prostate with different pathologies, and we compared the abilities of stromal cells from normal peripheral zone, benign prostatic hyperplasia (BPH-S), and cancer to induce the growth of a human prostatic epithelial cell line (BPH-1) in vivo. Using the tissue recombination method, we showed that grafting stromal cells (from any histology) alone or BPH-1 epithelial cells alone produced no visible grafts. Recombining stromal cells from normal peripheral zone with BPH-1 cells also produced no visible grafts (n = 15). Recombining BPH-S with BPH-1 cells generated small, well-organized, and sharply demarcated grafts approximately 3-4 mm in diameter (n = 9), demonstrating a moderate inductive ability of BPH-S. Recombining stromal cells from cancer with BPH-1 cells generated highly disorganized grafts that completely surrounded the host kidney and invaded into adjacent renal tissue, demonstrating induction of an aggressive phenotype. We conclude that acquisition of tissue from toluidine blue dye-stained specimens is an efficient method to generate high-quality epithelial and/or stromal cultures. Stromal cells derived by this method from areas of BPH and cancer induce epithelial cell growth in vivo, which mimics the natural history of these diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471963      PMCID: PMC3033046          DOI: 10.1210/en.2004-1123

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  Method for procuring specific populations of viable human prostate cells for research.

Authors:  A H Fischer; A Philips; P Taysavang; J K McKenney; M B Amin
Journal:  Lab Invest       Date:  2001-04       Impact factor: 5.662

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  Are primary cultures realistic models of prostate cancer?

Authors:  Donna M Peehl
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

4.  Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.

Authors:  G Dong; R Rajah; T Vu; A R Hoffman; R G Rosenfeld; C T Roberts; D M Peehl; P Cohen
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

5.  Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.

Authors:  D M Peehl; R G Sellers
Journal:  Exp Cell Res       Date:  1997-05-01       Impact factor: 3.905

Review 6.  Pathology of benign prostatic hyperplasia. Insight into etiology.

Authors:  J McNeal
Journal:  Urol Clin North Am       Date:  1990-08       Impact factor: 2.241

7.  25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.

Authors:  A M Barreto; G G Schwartz; R Woodruff; S D Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-03       Impact factor: 4.254

8.  Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.

Authors:  Anuradha Rao; Ralph D Woodruff; Wendy N Wade; Timothy E Kute; Scott D Cramer
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

Review 9.  Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation.

Authors:  Donald E Ingber
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

10.  Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis.

Authors:  Kathleen C Day; Michael T McCabe; Xin Zhao; Yuzhuo Wang; Joanne N Davis; John Phillips; Marion Von Geldern; Thomas Ried; Mark A KuKuruga; Gerald R Cunha; Simon W Hayward; Mark L Day
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  48 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

Authors:  Natalie Sampson; Rafal Koziel; Christoph Zenzmaier; Lukas Bubendorf; Eugen Plas; Pidder Jansen-Dürr; Peter Berger
Journal:  Mol Endocrinol       Date:  2011-01-27

3.  A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Authors:  Melanie J Grubisha; M E Cifuentes; Stephen R Hammes; Donald B Defranco
Journal:  Mol Endocrinol       Date:  2012-05-16

4.  Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.

Authors:  Hongjuan Zhao; Cristiane F Ramos; James D Brooks; Donna M Peehl
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

Review 5.  Hedgehog signaling in prostate growth and benign prostate hyperplasia.

Authors:  Chad M Vezina; And Wade Bushman
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 6.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 7.  A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia.

Authors:  Gerald R Cunha; William A Ricke
Journal:  Differentiation       Date:  2011-06-30       Impact factor: 3.880

8.  An Integrative Approach Toward Biology, Organisms, and Cancer.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Methods Mol Biol       Date:  2018

Review 9.  Human benign prostatic hyperplasia heterotransplants as an experimental model.

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-11-30       Impact factor: 3.285

10.  Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers.

Authors:  Rene Meyer; Viacheslav Fofanov; Anilk Panigrahi; Fatima Merchant; Nenggang Zhang; Debananda Pati
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.